EUVIMEDEUVIMED entdecken
Open Access

Pyrimidine-Dependent UV-Mediated Cross-Linking Magnifies Minor Genetic or Epigenetic Changes in Clinical Samples

Fangyan Yu, Farzana Ahmed, Stavroula Smilkou, Sayeda Yasmin-Karim, Farzaneh Darbeheshti, Athina Markou, Martyn Bullock, Ioannis Boukovinas, Viktor A Adalsteinsson, Evi Lianidou, G Mike Makrigiorgos iD

Clinical Chemistry · 2024

DOI: 10.1093/clinchem/hvae086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Fangyan Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. Hauptthemen laut MEDLINE: Ultraviolet Rays, Epigenesis, Genetic. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Detection of minor DNA allele alterations is becoming increasingly important for early detection and monitoring of cancer. We describe a new method that uses ultraviolet light to eliminate wild-type DNA alleles and enables improved detection of minor genetic or epigenetic changes.

Methods

Pyrimidine-dependent UV-based minor-allele enrichment (PD-UVME) employed oligonucleotide probes that incorporated a UVA-sensitive 3-cyanovinylcarbazole (CNVK), placed directly opposite interrogated pyrimidines, such as thymine (T) or cytosine (C) in wild-type (WT) DNA. Upon UVA-illumination, CNVK cross-linked with T/C, preventing subsequent amplification. Mutations that removed the T/C escaped cross-linking and were amplified and detected. Similarly, CNVK discriminated between methylated and unmethylated cytosine in CpG dinucleotides, enabling direct enrichment of unmethylated DNA targets. PD-UVME was combined with digital droplet PCR (ddPCR) to detect serine/threonine-protein kinase B-Raf (BRAF) V600E mutations in model systems, thyroid patient cancer tissue samples, and circulating DNA of tumor origin (ctDNA) from melanoma patients.

Results

One thyroid cancer sample out of 9, and 6 circulating-DNA samples out of 7 were found to be BRAF V600E-positive via PD-UVME while classified as negative by conventional ddPCR. Positive samples via conventional ddPCR were also found positive via PD-UVME. All 10 circulating cell-free DNA (cfDNA) samples obtained from normal volunteers were negative via both approaches. Furthermore, preferential enrichment of unmethylated alleles in MAGEA1 promoters using PD-UVME was demonstrated.

Conclusions

PD-UVME mutation/methylation enrichment performed prior to ddPCR magnifies low-level mutations or epigenetic changes and increases sensitivity and confidence in the results. It can assist with clinical decisions that hinge on the presence of trace alterations like BRAF V600E.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ultraviolet RaysEpigenesis, GeneticHumansPyrimidinesProto-Oncogene Proteins B-rafMutationMelanomaDNA MethylationAllelesThyroid NeoplasmsPolymerase Chain Reaction

Substanzen

PyrimidinesProto-Oncogene Proteins B-rafBRAF protein, humanpyrimidine

Autor:innen und Institutionen

  • Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
  • Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece.
  • Cancer Genetics Laboratory, Kolling Institute, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney & Northern Sydney Local Health District, St Leonards, NSW, Australia.
  • Bioclinic Thessaloniki Medical Oncology Unit, Department of Medical Oncology, Thessaloniki, Greece.
  • Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States.

ORCID-Profile: G Mike Makrigiorgos

Förderung

  • NCI NIH HHS
  • NIH HHS
  • European Union
  • National Institutes of Health

Zitieren

APA

Yu, F., Ahmed, F., Smilkou, S., Yasmin-Karim, S., Darbeheshti, F., Markou, A., Bullock, M., Boukovinas, I., Adalsteinsson, V. A., Lianidou, E., & Makrigiorgos, G. M. (2024). Pyrimidine-Dependent UV-Mediated Cross-Linking Magnifies Minor Genetic or Epigenetic Changes in Clinical Samples. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae086

Vancouver

Yu F, Ahmed F, Smilkou S, Yasmin-Karim S, Darbeheshti F, Markou A, et al. Pyrimidine-Dependent UV-Mediated Cross-Linking Magnifies Minor Genetic or Epigenetic Changes in Clinical Samples. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae086

BibTeX
@article{Yu2024,
  author = {Yu, Fangyan and Ahmed, Farzana and Smilkou, Stavroula and Yasmin-Karim, Sayeda and Darbeheshti, Farzaneh and Markou, Athina and Bullock, Martyn and Boukovinas, Ioannis and Adalsteinsson, Viktor A and Lianidou, Evi and Makrigiorgos, G Mike},
  title = {Pyrimidine-Dependent UV-Mediated Cross-Linking Magnifies Minor Genetic or Epigenetic Changes in Clinical Samples},
  journal = {Clinical Chemistry},
  year = {2024},
  doi = {10.1093/clinchem/hvae086}
}
Kostenlos starten →